Article Details

Why AstraZeneca and Surface Oncology Rose Today | The Motley Fool

Retrieved on: 2021-09-20 21:44:53

Tags for this article:

Click the tags to see associated articles and topics

Why AstraZeneca and Surface Oncology Rose Today | The Motley Fool. View article details on hiswai:

Excerpt

On Saturday, AstraZeneca provided an update about the phase 3 trial of its Imfinzi oncology drug in combination therapy for the treatment of one type of lung ...

Article found on: www.fool.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up